Skip to main content
Clinical Trials/NL-OMON34558
NL-OMON34558
Completed
Not Applicable

Identification of psychometric and biological markers to assess androgen and serotonergic sensitivity in relation to sexual functioning in women. - Androgen sensitivity in women.

Emotional Brain0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Female Sexual Dysfunction
Sponsor
Emotional Brain
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Provision of written informed consent;
  • 2\. Female 21\-70 years of age;
  • 3\. Healthy according to normal results of medical history
  • 4\. Subject must be heterosexually oriented;
  • 5\. BMI \>\= 18 and \<\= 30 kg/m2;
  • 6\. Dutch as first language;

Exclusion Criteria

  • 1\. Subjects who have had hand surgery interfering with measurement of digit lengths;
  • 2\. Subjects with musculoskeletal conditions affecting the measurements of digit lengths;
  • 3\. Known conditions associated with abnormal prenatal androgen exposure, namely congenital adrenal hyperplasia and complete androgen insensitivity syndrome;
  • 4\. Positive drug test and/or positive alcohol test;
  • 5\. Subjects with dyslexia;
  • 6\. Subjects who are color\-blind;
  • 7\. Positive urine pregnancy test;
  • 8\. Use of oral contraception containing anti\-androgens (e.g. Diane 35; Minerva);
  • 9\. Use of oral contraception containing 50 µg estrogen or more;
  • 10\. Homosexual orientation.

Outcomes

Primary Outcomes

Not specified

Similar Trials